Missouri's House Bill 840, introduced on January 10, 2025, aims to enhance patient rights regarding prescription drug access and management. Proposed by Representative Cook, the bill seeks to repeal existing sections of Missouri law and replace them with new provisions that prioritize patient choice and pharmacist consultation.

The primary focus of House Bill 840 is to ensure that patients retain the freedom to choose their pharmacy and receive prescriptions without undue restrictions from pharmacy benefits managers (PBMs). Key provisions include affirming patients' rights to obtain written or electronic prescriptions from their healthcare providers and allowing pharmacists to offer consultations on the safe use of medications. Notably, the bill prohibits PBMs from penalizing patients for choosing specific pharmacies or redirecting them to alternative options.

The introduction of this bill has sparked discussions among stakeholders, particularly regarding the role of PBMs in the healthcare system. Supporters argue that the legislation will empower patients and improve access to necessary medications, while critics express concerns about potential impacts on drug pricing and the overall healthcare market.

The implications of House Bill 840 could be significant, as it addresses ongoing debates about patient autonomy and the influence of PBMs in prescription drug management. Experts suggest that if passed, the bill could lead to increased competition among pharmacies, potentially lowering costs for consumers. However, the bill's future remains uncertain as it navigates the legislative process, with potential amendments and opposition likely to arise.

As Missouri lawmakers consider this bill, its outcome could reshape the landscape of prescription drug access in the state, reinforcing the importance of patient choice in healthcare decisions.